Since dysregulation of TBK1 activity is often associated with not only infectious disease, but also autoimmune disease and cancer, our identification of Ca2+-dependent TBC1D9-mediated TBK1 activation might help elucidate the pathogenesis of various diseases related to TBK1 and autophagy, as well as identify therapeutic targets. This evidence concerns the gene TBK1 and cancer.